Therapeutic Group

Indication Dosage

Temozolomide is a medication primarily used in the treatment of certain types of brain tumors, specifically glioblastoma multiforme and anaplastic astrocytoma. It is prescribed to patients as part of a comprehensive treatment plan, including surgery and radiation therapy, to slow down or inhibit the growth of cancer cells within the brain. Temozolomide works by interfering with the DNA replication process in rapidly dividing cancer cells, ultimately impeding their ability to proliferate.

Newly Diagnosed Glioblastoma Multiforme In Adults (in Combination With Radiotherapy) And Subsequently As Monotherapy, Second-line Treatment Of Malignant Glioma In Adults: 

• Adults: 150-200 Mg/m2/day For 5 Days, Repeat Every 28 Days (consult Product Literature)

Content

Pregnancy

Positive Evidence Of Risk: Avoid

Stability

Contra Indications

Precautions

Lactation

Side Effects